Zhejiang Wanliyang Co., Ltd. Financial Data
Consolidated
Consolidated Balance Sheet (B/S) |
(in millions yuan) |
FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | FY ended Mar. 31, 2020 | |
Current assets | 4,700.78 | 4,537.94 | 5,143.31 |
Illiquid assets | 5,390.08 | 5,464.69 | 6,437.55 |
Total assets | 10,090.86 | 10,002.63 | 11,580.86 |
Current liabilities | 3,964.14 | 4,301.14 | 4,627.96 |
Illiquid debts | 525.33 | 357.01 | 264.55 |
Total liabilities | 4,489.47 | 4,658.15 | 4,892.52 |
Capital | 1,312.60 | 1,340.00 | 1,340.00 |
Capital reserve | 2,840.83 | 3,036.01 | 3,036.01 |
Profit reserve | 290.75 | 290.75 | 290.75 |
Backlog profit | 1,148.42 | 851.00 | 2,189.15 |
Minority stock holders' equity | 8.78 | 31.86 | 37.58 |
Total stockholders' equity | 5,601.39 | 5,344.48 | 6,688.35 |
Total Liabilities and shareholders' equity | 10,090.86 | 10,002.63 | 11,580.86 |
Consolidated Profit and Loss Statement |
(in millions yuan) |
FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | FY ended Mar. 31, 2020 | |
Sales | 5,113.14 | 5,475.01 | 6,064.88 |
Operating profit | 299.69 | (743.97) | 674.53 |
Gross profit | 299.07 | (746.79) | 669.50 |
Net profit | 300.00 | (749.47) | 611.90 |
Consolidated Cash Flow |
(in millions yuan) |
FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | FY ended Mar. 31, 2020 | |
Cash flows from operating activities | 538.13 | 144.23 | 883.57 |
Cash flows from investing activities | (258.29) | 26.85 | (532.53) |
Cash flows from financing activities | (402.61) | (348.32) | (88.71) |
Increases (decreases) in cash and cash equivalents | (122.77) | (177.24) | 262.34 |
Cash and cash equivalent at the beginning of the term | 455.25 | 591.45 | 329.11 |
Cash and cash equivalents at the term-end | 332.48 | 414.21 | 591.45 |
Non-consolidated
Unconsolidated Balance Sheet (B/S) |
(in millions yuan) |
FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | FY ended Mar. 31, 2020 | |
Current assets | 3,732.35 | 3,574.07 | 4,245.39 |
Illiquid assets | 4,574.17 | 4,226.05 | 4,603.33 |
Total Assets | 8,306.52 | 7,800.12 | 8,848.72 |
Current liabilities | 3,338.14 | 2,674.20 | 2,688.37 |
Illiquid debts | 24.98 | 116.73 | 16.98 |
Total liabilities | 3,363.12 | 2,790.93 | 2,705.35 |
Capital | 1,312.60 | 1,340.00 | 1,340.00 |
Capital reserve | 2,908.89 | 3,097.14 | 3,097.14 |
Profit reserve | 290.75 | 290.75 | 290.75 |
Backlog profit | 431.16 | 486.44 | 1,620.62 |
Total stockholders' equity | 4,943.40 | 5,009.19 | 6,143.37 |
Total Liabilities and shareholders' equity | 8,306.52 | 7,800.12 | 8,848.72 |
Unconsolidated profit and loss statement |
(in millions yuan) |
FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | FY ended Mar. 31, 2020 | |
Sales | 844.88 | 1,338.20 | 2,005.67 |
Operating profit | (88.70) | (566.22) | 725.91 |
Gross profit | (84.91) | (566.97) | 722.30 |
Net profit | (55.28) | (543.51) | 688.05 |
Unconsolidated cash flow |
(in millions yuan) |
FY ended Mar. 31, 2022 | FY ended Mar. 31, 2021 | FY ended Mar. 31, 2020 | |
Cash flows from operating activities | (492.31) | (786.85) | (663.35) |
Cash flows from investing activities | 511.70 | 910.31 | 1,258.90 |
Cash flows from investing activities | (11.26) | (441.79) | (182.92) |
Increases (decreases) in cash and cash equivalents | 8.14 | (318.34) | 412.62 |
Cash and cash equivalent at the beginning of the term | 157.33 | 475.66 | 63.04 |
Cash and cash equivalents at the term-end | 165.46 | 157.33 | 475.66 |
Fiscal years ending in Dec. 31.